Biotechnology News

Nantes, France, 23 septembre 2026 – 7h30 CET – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE), une société de biotechnologie au stade clinique développant des...

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Sept. 22,...

Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 22 sept. 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext...

Mechelen, Belgium; September 22, 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ:...

Mechelen, België; 22 September 2026, 22.01 CET; gereglementeerde informatie In het kader van het op 9 juni 2026 aangekondigde inkoopprogramma maakt Lakefront Biotherapeutics NV (Euronext &...

IN8bio to Present at Sidoti Small-Cap Virtual Conference

Rep. Erin Houchin toured Ossium Health's Indianapolis facility, home to the world's first bone marrow bank sourced from deceased organ donors.

Applied Biologics announces Last Patient, Last Visit in CAMPX randomized trial of XWRAP.

Seek Labs has launched the Open Impact Sequence Ablation Therapeutics Program, a new Clinton Global Initiative Commitment to Action.

Publication of results from the Phase 2 BRAVIO clinical trial evaluating intravenous followed by oral varespladib for snakebite.